Catalyst

Slingshot members are tracking this event:

FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation Approved in U.S.

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
EGRX

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 24, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Docetaxel, Fda, Aproval, Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Adenocarcinoma, Head And Neck Cancer